Charles River Laboratories International CRL
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Charles River Laboratories International (CRL) Core Market Data and Business Metrics
Latest Closing Price
$149.28Price-Earnings Ratio
746.40Total Outstanding Shares
51.14 Million SharesDividend
No dividendSIC Description
Services-commercial Physical & Biological ResearchPrimary Exchange
New York Stock ExchangeHeadquarters
251 Ballardvale St, Wilmington, MA, 01887
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 1,166,242 Shares | 2.83 | 3/14/2025 | 3,301,195 Shares |
| 1,995,236 Shares | 1.47 | 2/28/2025 | 2,931,459 Shares |
| 1,027,280 Shares | 2.26 | 2/14/2025 | 2,319,466 Shares |
| 1,032,681 Shares | 1.93 | 1/31/2025 | 1,996,888 Shares |
| 834,394 Shares | 2.59 | 1/15/2025 | 2,157,296 Shares |
| 565,675 Shares | 3.99 | 12/31/2024 | 2,257,761 Shares |
Cash Flow Statement
December 31, 2023 to December 28, 2024
| Metric | Value |
|---|---|
| Net Cash Flow | $-78.91 Million |
| Net Cash Flow From Operating Activities | $734.58 Million |
| Exchange Gains/Losses | $-17.47 Million |
| Net Cash Flow From Financing Activities | $-550.93 Million |
| Net Cash Flow From Investing Activities | $-245.09 Million |
| Net Cash Flow From Operating Activities, Continuing | $734.58 Million |
Income Statement
December 31, 2023 to December 28, 2024
| Metric | Value |
|---|---|
| Net Income/Loss Available To Common Stockholders, Basic | $10.30 Million |
| Operating Expenses | $3.82 Billion |
| Costs And Expenses | $3.96 Billion |
| Net Income/Loss Attributable To Noncontrolling Interest | $3.09 Million |
| Income Tax Expense/Benefit, Deferred | $-67.19 Million |
| Other Operating Expenses | $3.07 Billion |
Comprehensive Income
December 31, 2023 to December 28, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $237,000 |
| Comprehensive Income/Loss Attributable To Parent | $-98.72 Million |
| Comprehensive Income/Loss | $-98.48 Million |
| Other Comprehensive Income/Loss | $-123.77 Million |
Balance Sheet
December 31, 2023 to December 28, 2024
| Metric | Value |
|---|---|
| Other Non-current Assets | $4.52 Billion |
| Liabilities | $4.02 Billion |
| Assets | $7.53 Billion |
| Noncurrent Assets | $6.13 Billion |
| Equity Attributable To Noncontrolling Interest | $5.45 Million |
| Accounts Payable | $140.34 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||